Skip to Content

IXCHIQ (Chikungunya vaccine (live)): Use restricted to individuals at high risk of acquiring chikungunya infection

30/07/2026
Medicines for human use Direct healthcare professional communication (DHPC)

Important Safety Information from Valneva Austria GmbH regarding IXCHIQ (Chikungunya vaccine (live)): Use restricted  to individuals at high risk of acquiring chikungunya infection

Documents

Opens in new window Ixchiq – Direct healthcare professional communication (DHPC) – 14 July 2026.pdf PDF : 969KB | 30/07/2026